Results 71 to 80 of about 294 (101)

Early-Onset Multiple Sclerosis: Reports of 300 Patients from Iran.

J Pediatr Neurosci, 2018
Omrani F, Sahraian MA, Saeen AA, Omrani Z, Hayeri G.   +4 more
europepmc   +1 more source

Apheresis for the treatment of relapses in MS and NMOSD: reduced antibody reactivities, gene expression changes and potential clinical response indicators. [PDF]

Front Immunol
Hecker M, Fitzner B, Ludwig-Portugall I, Bohne F, Heyland E, Klehmet J, Grothe M, Schwab M, Winkelmann A, Meister S, Dudesek A, Wurm H, Ayzenberg I, Kleiter I, Trebst C, Hümmert MW, Neumann B, Eulitz K, Koczan D, Zettl UK.   +19 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Outcome of Acute Monosymptomatic Optic Neuritis in Northern Sardinia, Italy

Neuro-Ophthalmology, 2007
Purpose: To define the outcome of acute monosymptomatic optic neuritis (AMON) in Northern Sardinia, Italy. Methods: Records of all AMON patients admitted at the Institute of Ophthalmology, University of Sassari, between 1991 and 2002 were reviewed.
Maura Pugliatti, Stefano Sotgiu, Antonio Pinna   +2 more
exaly   +4 more sources

Magnetic resonance imaging of the brain in patients with acute monosymptomatic optic neuritis

Acta Neurologica Scandinavica, 1989
Ophthalmologists and neurologists from a catchment area of 1.5 million people were asked to refer all patients with symptoms and signs of optic neuritis (ON) to our neurological department immediately. A total of 68 consecutive patients were extensively screened for known etiologies of ON.
H B Larsson
exaly   +3 more sources

Autoantibodies to the proteasome in monosymptomatic optic neuritis may predict progression to multiple sclerosis

Scandinavian Journal of Clinical and Laboratory Investigation, 2007
Proteasome autoantibodies (PAB) have been found in multiple sclerosis (MS) patient sera and cerebrospinal fluid (CSF). Presence of PAB could thus be a possible diagnostic marker for MS. We investigated whether PAB serum status in acute monosymptomatic optic neuritis (ON) and MS differed significantly from that of healthy controls, and whether or not ...
Gunnar Houen
exaly   +4 more sources

Prognostic Value of Magnetic Resonance Imaging in Monosymptomatic Optic Neuritis

Ophthalmology, 1996
Magnetic resonance imaging is able to depict lesions in the optic nerve in the acute stage of monosymptomatic optic neuritis. Most patients have lesions located intraorbitally, intracanalicularly, and/or intracranially. The goal of this study is to determine whether these lesions resolve after visual recovery, change in length or localization, or could
W Wiegand
exaly   +3 more sources

Cerebrospinal fluid myelin basic protein-like material in acute monosymptomatic optic neuritis

Acta Neurologica Scandinavica, 1996
Cerebrospinal fluid (CSF) may provide markers of severity and outcome of optic neuritis.We examined the CSF from 29 patients with acute monosymptomatic optic neuritis (AMON) for content of myelin basic protein-like material (MBPLM) and correlated the levels with results of cranial magnetic resonance imaging. The length of the time from onset of AMON to
J L, Frederiksen, J N, Whitaker
exaly   +3 more sources

MRI, VEP, SEP and biothesiometry suggest monosymptomatic acute optic neuritis to be a first manifestation of multiple sclerosis

Acta Neurologica Scandinavica, 1991
A cohort of 50 consecutive patients with acute monosymptomatic optic neuritis (ON) from a defined catchment area joined a prospective study. The aim of this study was to compare the sensitivity of magnetic resonance imaging (MRI), electrophysiological methods (VEP and SEP) and biothesiometry to detect abnormalities in other parts of the CNS than the ...
H B Larsson
exaly   +3 more sources

Correlation of magnetic resonance imaging and CSF findings in patients with acute monosymptomatic optic neuritis

Acta Neurologica Scandinavica, 1992
Acute monosymptomatic optic neuritis (AMON) may be the first indication of multiple sclerosis (MS), and this sign offers a special opportunity to study the very early clinical stages of MS. This prospective investigation compares results of CSF findings and magnetic resonance imaging (MRI) in a large, homogeneous and well-defined group of patients with
H B Larsson
exaly   +3 more sources